2016 International Congress

Wednesday, June 22, 2016

12:00pm-1:30pm

DTI in Parkinson’s disease: Asymmetric progression

L. Chan, K. Ng, C. Yeoh, H. Rumpel, E. Tan (Singapore, Singapore)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Dynamic dopamine transporter images are helpful for diagnosing parkinsonism

K. Abe, K. Fukushima, T. Katuura, K. Kitajima, Y. Maeda, K. Hahiskawa, H. Yoshikawa (Nishinomiya, Japan)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Dyskinesias-reduced-self-awareness and theory of mind in Parkinson’s disease: A novel frame of interpretation

S. Palermo, M. Amanzio, M. Zibetti, L. Lopiano (Turin, Italy)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Dysphagia in early stage Huntington’s disease (HD) – Pilot observations from a multimodal imaging study

I. Trender-Gerhard, E. Michou, A. Gerhard, D. Craufurd, S. Hamdy, K. Herholz (Manchester, United Kingdom)

Huntington's disease  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Dysregulations of GABAergic neurotransmission in Huntington’s disease brain

Y.T. Hsu, Y.G. Chang, H.M. Chen, Y. Chern (Taichung, Taiwan)

Huntington's disease  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Early clinical features of paraneoplastic cerebellar degeneration: Diagnostic outcomes of adult onset cerebellar ataxia

J. Zhang, Z. Xu, J.Y.H. Chai, L. Tan (Beijing, People's Republic of China)

Ataxia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Early grey matter changes in structural covariance networks in Huntington’s disease

E.M. Coppen, J. van der Grond, A. Hafkemeijer, S.A.R.B. Rombouts, R.A.C. Roos (Leiden, Netherlands)

Ataxiz, Choreas

12:00pm-1:30pm

EARLYSTIM: STN-DBS alleviates behavioural side effects of dopamine replacement therapy when compared to best medical treatment

E. Lhommée, W. Lars, C. Virginie, K. Witt, F. Maier, L. Tonder, L. Timmermann, T. Hälbig, F. Pineau, F. Durif, T. Witjas, J.L. Houeto, P. Krack (Grenoble, France)

Parkinson's disease: Psychiatric manifestations  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Effect of rivastigmine in Parkinson’s disease dementia – A logitudinal observational study

S. Raha, L. Ebenezer (Bridgend, United Kingdom)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Effectiveness of duodenal levodopa/carbidopa infusion gel (LCIG) therapy on the neuropsychiatric disturbances of advanced Parkinson’s disease (EDIS study)

M.J. Catalan, P. Montero, J. Herreros, J.M. Arbelo, P. Martinez-Martin (Madrid, Spain)

Parkinson's disease: Psychiatric manifestations  ·  Exhibit Hall located in Hall B, Level 2